Buscar
Kestra Medical Technologies Ltd
KMTSAñadir a la lista de seguimiento
26.090USD
+1.320+5.33%
Cierre 09-22 16:00（ET）
1.52BCap. mercado
PérdidaP/E TTM
Acerca de {index_name} Kestra Medical Technologies Ltd Compañía
Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.
Perfil de Kestra Medical Technologies Ltd
Símbolo de cotizaciónKMTS
Nombre de la empresaKestra Medical Technologies Ltd
Fecha de salida a bolsaMar 06, 2025
Director ejecutivoWebster (Brian Daniel)
Número de empleados330
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 06
Dirección3933 Lake Washington Blvd Ne
CiudadKIRKLAND
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal98033
Teléfono14252798002
Sitio Web
Símbolo de cotizaciónKMTS
Fecha de salida a bolsaMar 06, 2025
Director ejecutivoWebster (Brian Daniel)
Ejecutivos de Kestra Medical Technologies Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Traci S. Umberger
Ms. Traci S. Umberger
Chief Administrative Officer, General Counsel, Director
Chief Administrative Officer, General Counsel, Director
132.95K
-8.40%
Dr. Elizabeth Kwo, M.D.
Dr. Elizabeth Kwo, M.D.
Independent Director
Independent Director
18.13K
+39.82%
Mr. Conor Hanley
Mr. Conor Hanley
Independent Director
Independent Director
14.64K
+10.40%
Mr. Vaseem Mahboob
Mr. Vaseem Mahboob
Chief Financial Officer
Chief Financial Officer
7.42K
-520.85%
Mr. Brian Webster
Mr. Brian Webster
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
--
--
Ms. Debra Schotz
Ms. Debra Schotz
Senior Vice President - Marketing
Senior Vice President - Marketing
--
--
Mr. Al Ford
Mr. Al Ford
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Jeffrey Schwartz
Mr. Jeffrey Schwartz
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Toby AuWerter
Mr. Toby AuWerter
Independent Director
Independent Director
--
--
Mr. Maxwell Bikoff
Mr. Maxwell Bikoff
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Traci S. Umberger
Ms. Traci S. Umberger
Chief Administrative Officer, General Counsel, Director
Chief Administrative Officer, General Counsel, Director
132.95K
-8.40%
Dr. Elizabeth Kwo, M.D.
Dr. Elizabeth Kwo, M.D.
Independent Director
Independent Director
18.13K
+39.82%
Mr. Conor Hanley
Mr. Conor Hanley
Independent Director
Independent Director
14.64K
+10.40%
Mr. Vaseem Mahboob
Mr. Vaseem Mahboob
Chief Financial Officer
Chief Financial Officer
7.42K
-520.85%
Mr. Brian Webster
Mr. Brian Webster
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
--
--
Ms. Debra Schotz
Ms. Debra Schotz
Senior Vice President - Marketing
Senior Vice President - Marketing
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Kestra Medical Technologies Ltd?
Los cinco principales accionistas de Kestra Medical Technologies Ltd son: Ms. Traci S. Umberger
¿Cuántas instituciones poseen acciones de Kestra Medical Technologies Ltd (KMTS)?
A fecha de 2026Q1, 218 instituciones poseen acciones de Kestra Medical Technologies Ltd, con un valor de mercado combinado de aproximadamente 60.76M, lo que representa el 104.08% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 5705735.00.